Patents by Inventor Julia Adler

Julia Adler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10155949
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: December 18, 2018
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Yosef Shaul, Peter Tsvetkov, Julia Adler
  • Publication number: 20180087057
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Application
    Filed: December 7, 2017
    Publication date: March 29, 2018
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Yosef Shaul, Peter Tsvetkov, Julia Adler
  • Patent number: 9840711
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: December 12, 2017
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Yosef Shaul, Peter Tsvetkov, Julia Adler
  • Publication number: 20170175127
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 22, 2017
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Yosef SHAUL, Peter TSVETKOV, Julia ADLER
  • Patent number: 9579339
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Grant
    Filed: September 27, 2015
    Date of Patent: February 28, 2017
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Yosef Shaul, Peter Tsvetkov, Julia Adler
  • Publication number: 20160008390
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Application
    Filed: September 27, 2015
    Publication date: January 14, 2016
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Yosef SHAUL, Peter Tsvetkov, Julia Adler
  • Patent number: 9145559
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: September 29, 2015
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Yosef Shaul, Peter Tsvetkov, Julia Adler
  • Publication number: 20140288157
    Abstract: A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
    Type: Application
    Filed: October 25, 2012
    Publication date: September 25, 2014
    Inventors: Yosef Shaul, Peter Tsvetkov, Julia Adler